Skip to main content
Top
Published in: Allergy, Asthma & Clinical Immunology 1/2014

Open Access 01-12-2014 | Short report

Invasive group A Streptococcus disease in French-Canadian children is not associated with a defect in MyD88/IRAK4-pathway

Authors: Isabel Fernandez, Rose-Marie Brito, Philippe Bidet, Fabien Rallu, Celine Laferrière, Philippe Ovetchkine, Francoise Le Deist

Published in: Allergy, Asthma & Clinical Immunology | Issue 1/2014

Login to get access

Abstract

Background

Beta-hemolytic Group A Streptococcus invasive disease (iGASd) has been subject to intense research since its re-emergence in the late 1980s. In Quebec, an increase in the number of severe iGASd cases has recently been observed. Because of the inter-individual variability in the severity of iGASd, a hereditary predisposition to invasive disease can be suspected. Given that iGASd occurs in MyD88- and IRAK4-deficient patients, although rarely, the increasing frequency of iGASd in the population of French-Canadian children may be associated with a deficiency in the host’s innate immune response.

Methods

In this report, we assessed the influence of: (i) bacterial genotype and virulence factors, (ii) immune-cellular features, and (iii) Myd88/IRAK4-dependent response to GAS in vitro on the susceptibility to iGASd in a paediatric cohort of 16 children: 11 French-Canadian and 5 from diverse origin.

Findings

GAS virulence factors and genotype are not implicated in the susceptibility toward iGASd, and cellular and MyD88/IRAK4 deficiencies are excluded in our patients.

Conclusions

Although it has been shown that the MyD88/IRAK4-dependent signal is involved in the response to invasive GAS, our data indicates that a MyD88/IRAK4-mediated signalling defect is not the main factor responsible for the susceptibility to severe iGASd in a paediatric population from the province of Quebec.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hollm-Delgado M-G, Allard R, Pilon PA: Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal 1995–2001. Emer Infect Dis. 2005, 11: 77-82. 10.3201/eid1101.030651.CrossRef Hollm-Delgado M-G, Allard R, Pilon PA: Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal 1995–2001. Emer Infect Dis. 2005, 11: 77-82. 10.3201/eid1101.030651.CrossRef
2.
go back to reference Minodier P, Bidet P, Rallu F, Tapiero B, Bingen E, Ovetchkine P: Clinical and microbiologic characteristics of group A streptococcal necrotizing fasciitis in children. Pediatr Infect Dis. 2009, 28: 541-543. 10.1097/INF.0b013e318195bb10.CrossRef Minodier P, Bidet P, Rallu F, Tapiero B, Bingen E, Ovetchkine P: Clinical and microbiologic characteristics of group A streptococcal necrotizing fasciitis in children. Pediatr Infect Dis. 2009, 28: 541-543. 10.1097/INF.0b013e318195bb10.CrossRef
3.
go back to reference Goldmann O, Chhatwal GS, Medina E: Immune mechanisms underlying host susceptibility to infection with group A streptococci. J Infect Dis. 2003, 187: 854-861. 10.1086/368390.CrossRefPubMed Goldmann O, Chhatwal GS, Medina E: Immune mechanisms underlying host susceptibility to infection with group A streptococci. J Infect Dis. 2003, 187: 854-861. 10.1086/368390.CrossRefPubMed
4.
go back to reference Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M: Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol. 2000, 30: 3247-3255. 10.1002/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO;2-D.CrossRefPubMed Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M: Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol. 2000, 30: 3247-3255. 10.1002/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO;2-D.CrossRefPubMed
5.
go back to reference Medvedev AE, Lentschat A, Kuhns DB: Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med. 2010, 198: 521-531.CrossRef Medvedev AE, Lentschat A, Kuhns DB: Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med. 2010, 198: 521-531.CrossRef
6.
go back to reference Picard C, von Bernuth H, Ghandil P: Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore). 2010, 89: 403-425. 10.1097/MD.0b013e3181fd8ec3.CrossRef Picard C, von Bernuth H, Ghandil P: Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore). 2010, 89: 403-425. 10.1097/MD.0b013e3181fd8ec3.CrossRef
7.
go back to reference Laberge AM, Michaud J, Richter A: Population history and its impact on medical genetics in Quebec. Clin Genet. 2005, 68: 287-301. 10.1111/j.1399-0004.2005.00497.x.CrossRefPubMed Laberge AM, Michaud J, Richter A: Population history and its impact on medical genetics in Quebec. Clin Genet. 2005, 68: 287-301. 10.1111/j.1399-0004.2005.00497.x.CrossRefPubMed
8.
go back to reference Loof TG, Goldmann O, Medina E: Immune recognition of streptococcus pyogenes by dendritic cells. Infect Immun. 2008, 76: 2785-2792. 10.1128/IAI.01680-07.PubMedCentralCrossRefPubMed Loof TG, Goldmann O, Medina E: Immune recognition of streptococcus pyogenes by dendritic cells. Infect Immun. 2008, 76: 2785-2792. 10.1128/IAI.01680-07.PubMedCentralCrossRefPubMed
9.
go back to reference Gratz N, Hartweger H, Matt U, Kratochvill F: Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection. PLoS Pathogens. 2011, 7: e1001345-10.1371/journal.ppat.1001345.PubMedCentralCrossRefPubMed Gratz N, Hartweger H, Matt U, Kratochvill F: Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection. PLoS Pathogens. 2011, 7: e1001345-10.1371/journal.ppat.1001345.PubMedCentralCrossRefPubMed
10.
go back to reference Gratz N, Siller M, Schaljo B: Group A streptococcus activates type i interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9. J Biol Chemistry. 2008, 283: 19879-19887. 10.1074/jbc.M802848200.CrossRef Gratz N, Siller M, Schaljo B: Group A streptococcus activates type i interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9. J Biol Chemistry. 2008, 283: 19879-19887. 10.1074/jbc.M802848200.CrossRef
Metadata
Title
Invasive group A Streptococcus disease in French-Canadian children is not associated with a defect in MyD88/IRAK4-pathway
Authors
Isabel Fernandez
Rose-Marie Brito
Philippe Bidet
Fabien Rallu
Celine Laferrière
Philippe Ovetchkine
Francoise Le Deist
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Allergy, Asthma & Clinical Immunology / Issue 1/2014
Electronic ISSN: 1710-1492
DOI
https://doi.org/10.1186/1710-1492-10-9

Other articles of this Issue 1/2014

Allergy, Asthma & Clinical Immunology 1/2014 Go to the issue